The US named included India, China and Pakistan in its list of “major drug transit or major illicit drug producing countries” for fiscal year 2027, while separately identifying Afghanistan, Bolivia, Burma and Colombia as countries that failed demonstrably to meet their international counternarcotics obligations.
The presidential determination, submitted to Congress, covers 23 countries and clarified that inclusion on the list does not necessarily reflect a government’s current counternarcotics efforts or its cooperation with the US.
